PMC members shape and advance the future of personalized medicine.
» Sign Up Today
March 30 | BioTech Pharma Summit '17
April 06 | 2017 +Dx Diagnostics Forum
In an article titled "Strategies for Integrating Personalized Medicine into Health Care Practice" recently submitted for publication in the journal Personalized Medicine, PMC's Health Care Working Group presents a set of strategies to overcome challenges in integrating personalized medicine into health care systems. The paper offers solutions to problems in five strategic areas, including education & awareness, patient empowerment, value recognition, infrastructure and access to care.
» "Strategies for Integrating Personalized Medicine into Health Care Practice"
A new report from the Personalized Medicine Coalition (PMC) shows that in 2016, for the third year in a row, personalized medicines accounted for more than 20 percent of the new molecular entities (NMEs) approved by the U.S. Food and Drug Administration (FDA). PMC President Edward Abrahams said the trend reflects the pharmaceutical industry’s commitment to investing in personalized medicine despite the absence of a business model that ensures success and persistent barriers in public policy that slow the transition from a one-size-fits-all world to one that is based on delivering the right medicine to the right patient at the right time.
» Personalized Medicine at FDA: 2016 Progress Report